(2020) Simultaneous Determination of Docetaxel and Celecoxib in Porous Microparticles and Rat Plasma by Liquid-Liquid Extraction and HPLC with UV Detection: in vitro and in vivo Validation and Application. Journal of Pharmacy and Pharmaceutical Sciences. pp. 289-303. ISSN 1482-1826
Text
13929.pdf Download (1MB) |
Abstract
Purpose: A simple, rapid, sensitive, and reliable HPLC method with UV detection was developed and validated for simultaneous quantitation of docetaxel and celecoxib and paclitaxel for dissolution characterization and pharmacokinetic studies. Methods: The HPLC assay was performed isocratically on a reversed-phase C18 mu-Bondapack column using a mobile phase of acetonitrile:water (45:55, v/v) at a flow rate of 1.2 mL/min, and the analytes were detected at 230 nm. Paclitaxel was used as an internal standard for analysis of plasma samples following simple liquid-liquid extraction with n-hexane:isoamyl alcohol (97:3). The method was validated for specificity, linearity, sensitivity, precision, accuracy, robustness, and in vitro-in vivo application. Results: The retention times for docetaxel, paclitaxel, and celecoxib were 10.94, 12.4, and 16.81 min, respectively. The standard curves covering 0.1-1 mu g/mL and 0.05-4 mu g/mL were linear using dissolution medium and rat plasma, respectively. The limit of quantitation of the method was 50 ng/mL using 100 mu L of rat plasma sample and injection of 50 mu L of the residue. Within- and between-day precision and accuracy did not exceed 16.86 and 12.10, respectively. This validated method was successfully used to quantify docetaxel and celecoxib simultaneously in the release study of docetaxel-celecoxib -loaded porous microparticles and pharmacokinetics studies. The methods were found to be simple, specific, precise, accurate, and reproducible. In this study, paclitaxel was used as the internal standard while dexamethasone, flutamide, and budesonide proved suitable alternative as an internal standard. Conclusion: Since docetaxel and celecoxib could be co-administered for the treatment of a wide range of cancers such as non-small cell lung carcinoma, the developed method is particularly advantageous for routine therapeutic drug monitoring and pharmacokinetic studies of these drugs.
Item Type: | Article |
---|---|
Keywords: | CELL LUNG-CANCER SOLID-PHASE EXTRACTION TISSUE DISTRIBUTION ANTITUMOR-ACTIVITY CHROMATOGRAPHIC METHOD ANTICANCER DRUGS CO-DELIVERY EXPRESSION CYCLOOXYGENASE-2 PHARMACOKINETICS |
Subjects: | QV Pharmacology |
Divisions: | Faculty of Pharmacy and Pharmaceutical Sciences > Department of Pharmacotherapy |
Page Range: | pp. 289-303 |
Journal or Publication Title: | Journal of Pharmacy and Pharmaceutical Sciences |
Journal Index: | ISI |
Volume: | 23 |
Identification Number: | https://doi.org/10.18433/jpps30912 |
ISSN: | 1482-1826 |
Depositing User: | Zahra Otroj |
URI: | http://eprints.mui.ac.ir/id/eprint/13929 |
Actions (login required)
View Item |